Abstract:Background: Individuals are exposed to various volatile organic compounds (VOCs) in their surroundings. VOCs were associated with some cardiovascular and metabolic diseases, but the effects on blood pressure (BP) have not yet been clarified. This study aimed to ascertain the relationship between the urine levels of VOCs and the prevalence of hypertension (HTN) in the general population. Methods: This analysis utilized data from 4156 participants aged from 20 to 79 years in 2013–2018 National Health and Nutrition Examination Survey (NHANES). Exposure to VOCs was assessed through measurements of urinary VOC metabolites, with 16 VOCs selected for analysis. The relationships between VOCs and the risk of HTN in patients were examined through the weighted logistic regression and the weighted linear regression models. Generalized additive models were employed to analyze potential nonlinear associations between VOCs and the risk of HTN. Additionally, subgroup analyses and intergroup interaction tests were conducted. Results: A total of 4156 participants with 16 VOCs were finally included for analysis. Multivariable logistic regression showed that ln-transformed urine levels of N -acetyl-S-(2-cyanoethyl)-L-cysteine (CYMA) [odds ratio (OR) 1.54; 95% confidence interval (CI) 1.18–2.02], N -acetyl-S-(3-hydroxypropyl)-L-cysteine (3HPMA; OR 1.33; 95% CI 1.03–1.74), N -acetyl-S-(4-hydroxy-2-butenyl)-L-cysteine (MHBMA3; OR 1.68; 95% CI 1.29–2.20), and N -acetyl-S-(1-phenyl-2-hydroxyethyl)-L-cysteine + N -acetyl-S-(2-phenyl-2-hydroxyethyl)-L-cysteine (PHEMA; OR 1.55; 95% CI 1.19–2.00) were significantly associated with an increased risk of HTN in US general population. A nonlinear relationship and a threshold effect were only observed between ln ( N -acetyl-S-(2-hydroxypropyl)-L-cysteine or 2HPMA) and HTN. There was a significantly positive correlation between ln(2HPMA) and HTN when ln(2HPMA) at least 5.29. Sub-analysis revealed that there was a more pronounced association in the elderly group (age ≥60 years), the overweight group (BMI ≥25), and the alcohol consumption group. Conclusion: Our work presents novel epidemiological evidence supporting the establishment of the relationship between environmental pollutants and HTN, highlighting hitherto ignored positive correlations between nonoccupational VOC exposure and the entire population's risk of HTN.

Associations between specific volatile organic chemical exposures and cardiovascular disease risks: insights from NHANES

Association between urinary metabolites of volatile organic compounds and cardiovascular disease in the general population from NHANES 2011–2018

Exposure to volatile organic compounds and mortality in US adults: A population-based prospective cohort study

Associations of urinary volatile organic compounds with cardiovascular disease among the general adult population

Association of the blood levels of specific volatile organic compounds with nonfatal cardio-cerebrovascular events in US adults

Biological aging mediates the association between volatile organic compounds and cardiovascular disease

Combined association of urinary volatile organic compounds with chronic bronchitis and emphysema among adults in NHANES 2011–2014: The mediating role of inflammation

Impact of Polyfluoroalkyl Chemicals and Volatile Organic Compounds Exposure on Lung Function of American Adults

Associations of Individual and Mixture Exposure to Volatile Organic Compounds with Metabolic Syndrome and Its Components among US Adults

Association of volatile organic compound levels with chronic obstructive pulmonary diseases in NHANES 2013–2016

The exposure to volatile organic compounds associate positively with overactive bladder risk in U.S. adults: a cross-sectional study of 2007–2020 NHANES

Increased levels of urine volatile organic compounds are associated with hypertension risk

Blood Volatile Organic Aromatic Compounds Concentrations Across Adulthood in Relation to Total and Cause Specific Mortality: A Prospective Cohort Study.

Associations between the compositional patterns of blood volatile organic compounds and chronic respiratory diseases and ages at onset in NHANES 2003-2012

Exposure to Acrylamide and the Risk of Cardiovascular Diseases in the National Health and Nutrition Examination Survey 2003–2006

Assessing volatile organic compounds exposure and chronic obstructive pulmonary diseases in US adults

Identifying cardiovascular disease risk in the U.S. population using environmental volatile organic compounds exposure: A machine learning predictive model based on the SHAP methodology

Association between Ambient Volatile Organic Compounds Exposome and Emergency Hospital Admissions for Cardiovascular Disease

Comprehensive analysis between volatile organic compound (VOC) exposure and female sex hormones: a cross-sectional study from NHANES 2013–2016

Source-Specific Volatile Organic Compounds and Emergency Hospital Admissions for Cardiorespiratory Diseases.

Exposure to Volatile Organic Compounds and Blood Pressure in NHANES 2011 to 2018